Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

25. Juillet 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1968


	Articles 1 - 20 / 39351

	Comparison of the diagnostic value of white light endoscopic, narrow band imaging, and iodine staining individually and in combination for early esophageal cancer and precancerous lesions. Front Oncol Yin X, Meng M. PMID: 42500285 [PubMed]
	Performance of DeepSeek V3 and ChatGPT-4o in answering esophageal cancer-related questions. Medicine (Baltimore) Yang Q, Yi J, Gong A, Li Y, Feng Q, Fu A, Li J, Zhan Y. PMID: 42499121 [PubMed - indexed for MEDLINE]
	Essential Updates 2024-2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization. Ann Gastroenterol Surg Oya S, Yagi K, Baba Y. PMID: 42495683 [PubMed - as supplied by publisher]
	Systematic Review and Meta-Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma. Ann Gastroenterol Surg Sakai M, Kuriyama K, Nagai K, Shirabe K, Saeki H. PMID: 42495669 [PubMed - as supplied by publisher]
	Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials. Front Immunol Ye Y, Zhang L, Yang Z, Huang Y, Chen M, Zhang S, Zeng T, Chen C, Zheng B. PMID: 42495613 [PubMed - indexed for MEDLINE]
	Circular RNAs in esophageal squamous cell carcinoma: What do we know so far? iScience Yang M, Ye J, Xiong J, Chen Y, Zhao Y, Wang Z, Xu S, Wang J. PMID: 42495543 [PubMed]
	Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study. Front Oncol Jingu K, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Harada H, Takahashi M, Kamei T, Matsushita H. PMID: 42494587 [PubMed]
	Does adding immunotherapy to neoadjuvant chemotherapy increase postoperative morbidity in gastroesophageal junction adenocarcinoma? A propensity score-matched study. Front Immunol Zhang H, Huang Q, Du J, Wan X. PMID: 42490951 [PubMed - indexed for MEDLINE]
	A Simplified Nomogram for Primary Population-Based Screening of Esophageal Cancer: An Internally Validated Shandong Cohort Study Addressing Data Imbalance. Risk Manag Healthc Policy Hou J, He X, Gao F, Ren T, Ren L, Wang X. PMID: 42488795 [PubMed]
	Targeting notch signaling pathway in esophageal cancer: from molecular insights to therapies. Oncol Rev Bhattacharyya S, Ghosh H, Hamza A, Biersack B, Gan GN, Sharma P, Dandawate P. PMID: 42488503 [PubMed]
	Additional chemoradiotherapy versus esophagectomy for early esophageal cancer: an integrated analysis of reconstructed time-to-event data. Ther Adv Gastroenterol Huang PF, Chen YG, Lu MC, Yang CW. PMID: 42488030 [PubMed]
	Prognostic Factors in Upper Gastrointestinal Neuroendocrine Carcinoma: A Retrospective Cohort Study of Clinicopathological Features and Survival Outcomes. Cancer Manag Res , Gökmen A. PMID: 42483270 [PubMed]
	Extent of Lymphadenectomy in Esophageal Cancer Surgery: Unresolved Issues in Prophylactic 3-Field Dissection. J Chest Surg Tsunoda S, Sakaguchi M, Okumura S, Kitano S, Obama K. PMID: 42482330 [PubMed - as supplied by publisher]
	Circulating Tumor DNA Sequencing for Early Diagnosis and Detection of Treatment Response, Minimal Residual Disease, and Recurrence in Gastroesophageal Cancer. J Gastrointest Cancer Henriksen MM, Rudbeck AV, Detlefsen S, Mortensen MB, Pfeiffer P, Kruse TA, Thomassen M. PMID: 42481836 [PubMed - indexed for MEDLINE]
	A Rare Case of Gastric Cancer Following Sleeve Gastrectomy with Transit Bipartition Surgery: A Case Report and Review of the Literature. Chirurgia (Bucur) Güler SA, Ma, Varol E, , . PMID: 42478989 [PubMed - indexed for MEDLINE]
	The Dysregulation of Lysine Acetylation in Esophageal Squamous Cell Carcinoma: Mechanisms, Therapeutic Targets and Clinical Perspectives. Technol Cancer Res Treat Zhai Y, Wang Y, Weng Q, Feng X, Guo Y, Zou B, Zhang L. PMID: 42478448 [PubMed - indexed for MEDLINE]
	Incidence, risk factors and tumor spectrum of second primary cancers after gastric cancer: a multicenter cohort study with long-term follow-up. BMC Med Gao X, Han W, Lu L, Xi H, Yu J, Liang Y, Zhao L, Tan Z, Li X, Zhang Z, Fei W, Zheng R, Zhang D, Wang S, Yue C, Chen L, Fan H, Zhang H, Zhang F, Hu J, Lu L, Nie P, Zhao Q, Liu H, Wu K, Chen Y, Li G, Shang L, Nie Y, Multidisciplinary Alliance of Gastric Integrative Studies (MAGIS) Group. PMID: 42477705 [PubMed - as supplied by publisher]
	ASO Visual Abstract: A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma. Ann Surg Oncol Rusidanmu A, Zhou K, Zhu X, Zheng D, Tu Z, Jiang H, Yang R, Liu K, Zhang H, Ye X, Yu H, Yu H, Xu P, Zhi S, Jing J, Wu X, Wu G, Peng C, Peng X, Huang B, Zheng Y, Ye P. PMID: 42474965 [PubMed - as supplied by publisher]
	Treatment strategies for postoperative locoregional recurrent esophageal squamous cell carcinoma after curative resection: a narrative review. Esophagus Jingu K, Umezawa R, Yamamoto T, Takahashi N, Harada K, Suzuki Y, Kishida K, Omata S, Harada H, Chiba N, Okuda S, Uchimi S, Hirano M, Takahashi Y, Mori K. PMID: 42474874 [PubMed - as supplied by publisher]
	Zolbetuximab-induced gastric mucosal injury and hypoalbuminemia: a mechanism-informed clinical analysis. Cancer Chemother Pharmacol Yanagimoto Y, Yamamoto K, Yamamoto K, Masuike Y, Ushimaru Y, Omori T, Sakai D, Kudo T, Matsuura N, Sugase T, Kanemura T, Mori R, Kubo M, Fukuda Y, Kitakaze M, Komatsu H, Miyo M, Sueda T, Nishimura J, Kagawa Y, Goto K, Kobayashi S, Miyata H. PMID: 42474748 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39351

Page 1 de 1968



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité